Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
George Rehm
AddedFeb 15, 2024
UpdatedMay 31, 2026
George Rehm

George Rehm

Board Member, InkSpace Imaging

Crunchbase

George Rehm's Career

InkSpace Imaging
InkSpace Imaging

Moraga, CA, US

Board Member· Board
Tethys Bioscience
Tethys Bioscience

Emeryville, CA, US

Board Member· Board
Artera
Artera

Los Altos, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

George Rehm's Career

InkSpace Imaging
InkSpace Imaging
Series A$13.7M202016Moraga, CA, US
Board Member· Board

Leadership at InkSpace Imaging

Michael LustigMichael LustigCo-Founder
Balthazar LecheneBalthazar LecheneCo-Founder
Joseph CoreaJoseph CoreaCo-Founder
Peter FischerPeter FischerCEO
Ana Claudia AriasAna Claudia AriasCo-Founder
Tethys Bioscience
Tethys Bioscience
Public$75.4M752002Emeryville, CA, US
Board Member· Board

Leadership at Tethys Bioscience

Brook ByersBrook ByersBoard Member
Bill EricsonBill EricsonBoard Member
Randy StrahanRandy StrahanBoard Member
Gregory T WentGregory T WentBoard Member

Similar to Tethys Bioscience

Liquid BiotechLiquid BiotechPhiladelphia, PA, USBlood Testsest. 2012Liquid BiotechPhiladelphia, PA, US · est. 2012

Liquid Biotech USA: Developing non-invasive blood tests for a healthier future.

Seed · $2M6
Thetis PharmaceuticalsThetis PharmaceuticalsRidgefield, CT, USDrug Developmentest. 2011Thetis PharmaceuticalsRidgefield, CT, US · est. 2011

Thetis Pharmaceuticals: Specializing in cardio-metabolic, cancer, and autoimmune disease treatments.

Series A · $22.9M30
Predictive BiosciencesPredictive BiosciencesLexington, KY, USCancer Testsest. 2006Predictive BiosciencesLexington, KY, US · est. 2006

Predictive Biosciences develops molecular tests and technologies for cancer diagnosis and monitoring in the US.

Pre-Seed · $68.1M75
Gryphon BioGryphon BioSouth San Francisco, CA, USBlood Tests, Diagnosticsest. 2018Gryphon BioSouth San Francisco, CA, US · est. 2018

Gryphon Bio: A preclinical-stage bioconjugate firm innovating in precision medicine and biomarker discovery.

Seed · $10M10
Artera
Artera
Series B$110M1752021Los Altos, CA, US
Board Member· Board

Leadership at Artera

Andre EstevaAndre EstevaFounder

Similar to Artera

ArteraArteraSanta Barbara, CA, USPatient Communicationsest. 2015ArteraSanta Barbara, CA, US · est. 2015

An AI-driven platform for the personalized treatment of localized prostate cancer.

Seed · $135.1M386
Precision Health AIPrecision Health AINew York City, NY, USHealthcare, Oncologyest. 2016Precision Health AINew York City, NY, US · est. 2016

Precision Health AI: Leveraging AI for oncology, enhancing outcomes and value-based care.

Series A · $20M30
Onc.AIOnc.AISan Carlos, CA, USOncology Softwareest. 2020Onc.AISan Carlos, CA, US · est. 2020

Creating precision oncology software for clinical use, with a focus on physician-centered products.

Series A · $31M30
Ataraxis AIAtaraxis AINew York, NY, USest. 2023Ataraxis AINew York, NY, US · est. 2023

Ataraxis AI develops AI-powered precision medicine tools for cancer care, integrating digital pathology and clinical data to personalize treatment selection.

Series A · $20.4M

George Rehm's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to George Rehm

Andy TeichAndy TeichBoard Member · Sensata TechnologiesSean DaSean DaBoard Member · Nebula MicrosystemsIttai HarelIttai HarelBoard Member · TScan TherapeuticsDennis AusielloDennis AusielloBoard Member · Alnylam Pharmaceuticals alnFord TamerFord TamerBoard Member · TeradyneGeorge MuellerGeorge MuellerBoard Member · Ecosense Lighting